These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22795728)

  • 1. Polymeric nanoparticles containing taxanes enhance chemoradiotherapeutic efficacy in non-small cell lung cancer.
    Jung J; Park SJ; Chung HK; Kang HW; Lee SW; Seo MH; Park HJ; Song SY; Jeong SY; Choi EK
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):e77-83. PubMed ID: 22795728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration.
    Lee E; Kim H; Lee IH; Jon S
    J Control Release; 2009 Dec; 140(2):79-85. PubMed ID: 19712714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antitumor efficiency of docetaxel and curcumin against lung cancer.
    Yin H; Guo R; Xu Y; Zheng Y; Hou Z; Dai X; Zhang Z; Zheng D; Xu H
    Acta Biochim Biophys Sin (Shanghai); 2012 Feb; 44(2):147-53. PubMed ID: 22126905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies.
    Shalinsky DR; Brekken J; Zou H; Bloom LA; McDermott CD; Zook S; Varki NM; Appelt K
    Clin Cancer Res; 1999 Jul; 5(7):1905-17. PubMed ID: 10430098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferrin coupled vesicular system for intracellular drug delivery for the treatment of cancer: development and characterization.
    Vaidya B; Vyas SP
    J Drug Target; 2012 May; 20(4):372-80. PubMed ID: 22339366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: in vitro and in vivo studies.
    Xue X; Sun DF; Sun CC; Liu HP; Yue B; Zhao CR; Lou HX; Qu XJ
    Lung Cancer; 2012 Jun; 76(3):300-8. PubMed ID: 22261315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cationic liposome-mediated nitric oxide synthase gene therapy enhances the antitumor effects of cisplatin in lung cancer.
    Ye S; Yang W; Wang Y; Ou W; Ma Q; Yu C; Ren J; Zhong G; Shi H; Yuan Z; Su X; Zhu W
    Int J Mol Med; 2013 Jan; 31(1):33-42. PubMed ID: 23128378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
    Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
    Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin.
    Mo Y; Lim LY
    J Control Release; 2005 Nov; 108(2-3):244-62. PubMed ID: 16213056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the microenvironment for radiosensitization by patupilone.
    Bley CR; Jochum W; Orlowski K; Furmanova P; Vuong V; McSheehy PM; Pruschy M
    Clin Cancer Res; 2009 Feb; 15(4):1335-42. PubMed ID: 19228735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cisplatin‑incorporated liposome that targets the epidermal growth factor receptor enhances radiotherapeutic efficacy without nephrotoxicity.
    Jung J; Jeong SY; Park SS; Shin SH; Ju EJ; Choi J; Park J; Lee JH; Kim I; Suh YA; Hwang JJ; Kuroda S; Lee JS; Song SY; Choi EK
    Int J Oncol; 2015 Mar; 46(3):1268-74. PubMed ID: 25544240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
    Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H
    Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy.
    Ling C; Xie Y; Zhao D; Zhu Y; Xiang J; Yang J
    Cancer Gene Ther; 2012 Oct; 19(10):697-706. PubMed ID: 22863759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weekly paclitaxel with and without concurrent radiation therapy: toxicity, pharmacokinetics, and response.
    Glantz MJ; Choy H; Akerley W; Kearns CM; Egorin MJ; Rhodes CH; Cole BF
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):128-35. PubMed ID: 9007140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nimesulide, a selective COX-2 inhibitor, acts synergistically with ionizing radiation against A549 human lung cancer cells through the activation of caspase-8 and caspase-3.
    Kim BM; Won J; Maeng KA; Han YS; Yun YS; Hong SH
    Int J Oncol; 2009 May; 34(5):1467-73. PubMed ID: 19360361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
    Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
    Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel and simultaneous radiation in locally advanced stage IIIA/B non-small cell lung cancer: a clinical phase I study.
    Vogt HG; Kolotas C; Martin T; Schneider LV; Goes-Schmieder R; Mitrou PS; Diergarten K; Kober B; Zamboglou N
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):120-3. PubMed ID: 9007138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer.
    Fahham D; Weiss ID; Abraham M; Beider K; Hanna W; Shlomai Z; Eizenberg O; Zamir G; Izhar U; Shapira OM; Peled A; Wald O
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1167-1175.e1. PubMed ID: 22925564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models.
    Springate CM; Jackson JK; Gleave ME; Burt HM
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):239-47. PubMed ID: 15864591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.